RFK Jr. wants every American to be wearing a fitness tracker within 4 years — here's what we know so far
And now, US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has said he'd like to see every American wearing some form of health or fitness device by 2029.
'My vision is that every American is wearing a wearable within four years,' he said at a congressional hearing last week. It was announced, his department will soon begin one of 'the biggest campaigns in HHS history,' which it says will help Americans 'take control over their own health.'
We don't know the details just yet. It isn't clear, for example, whether the government will subsidize existing devices to make them more affordable or release a Trump-branded health tracker, following the recent Trump phone.
During the congressional hearing, Kennedy Jr. said that his agency, which is behind the 'Make America Healthy Again', or MAHA, movement, is exploring ways to make the cost of blood glucose monitors more accessible.
He also suggested that an $80 wearable might be a better solution to the weight-loss drug Ozempic for controlling diabetes and weight, describing friends who 'lost their diabetes' after wearing glucose monitors.
Evidence shows diet and exercise changes can reverse Type 2 diabetes, and that glucose monitoring can be effective in motivating patients to make better decisions.
Get instant access to breaking news, the hottest reviews, great deals and helpful tips.
At the time of writing, we don't have a lot of information about what this campaign might look like, but questions have been raised about the safety of users' health data.
Would the government or insurance providers have access to our fitness tracker data? And how would our privacy be protected?
It's also worth noting that while fitness trackers are an excellent resource, they won't be suitable for everyone. It's estimated that 28.8 million Americans will suffer from an eating disorder in their lifetime, and psychologists have tracked a recent rise in orthorexia, body dysmorphia, and anxiety.
These disorders can all be aggravated by the influx of data you receive while wearing a fitness tracker.
On the surface, however, fitness trackers have the potential to help you make healthier choices and gain a deeper understanding of your overall health. Trackers like the Apple Watch will alert you if it detects an irregular heart rhythm, which could save your life.
But this isn't a one-size-fits-all solution, and a fitness tracker can never replace guidance from medical professionals. Ultimately, fitness trackers are only a piece of the health puzzle, and right now, we have more questions than answers
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
2 minutes ago
- Fox News
Clint Eastwood's longtime secrets of good health and longevity revealed
At 95, American movie star and film director Clint Eastwood is still going strong. Celebrity biographer Shawn Levy, author of the book "Clint: The Man and the Movies," has written about the health practices that have contributed to the actor's longevity. In a recent Air Mail article, Levy noted that Eastwood is a "lifelong gym rat and fitness freak" who has also favored an "organic, low-fat diet" since the 1950s, "when alfalfa sprouts and yogurt were considered exotic." "And in the 60s, he was touting the benefits of sushi," he added. Eastwood has also practiced Transcendental Meditation daily, often twice a day, since the mid-1970s, even while working, according to Levy. "Indeed, especially while working," he wrote. "All this while playing the Man with No Name and Dirty Harry and other such avatars of bloodshed." Levy referred to Eastwood as a "man of contradictions" as he alternates between his rough-and-tumble movie roles and meditation sessions behind the scenes, describing how the actor has "mirrored the best and worst" of our "national character." Transcendental Meditation (TM) is a meditation technique that provides deep rest for the mind and body, according to the official TM website. The meditative practice "dissolves stress" in the nervous system, which can improve brain function. "After just a few minutes of TM practice, people typically feel more refreshed, clear-minded and ready for action," according to the website. "Over time, consciousness develops, and we enjoy greater success and happiness in life. TM practitioners report inner peace, more creativity, better health and better relationships." For more Health articles, visit In a medically reviewed WebMD guide, experts share how the TM technique can help people avoid distracting thoughts and promote a state of "relaxed awareness" by using a mantra to focus attention. Some TM supporters state that ordinary thinking is "transcended" and replaced by a "state of pure consciousness," where perfect stillness, rest, stability, order and "absence of mental boundaries" are achieved, the above source noted. Potential health benefits of the practice can include reduced stress, anxiety and depression, as well as lower blood pressure and better sleep. While TM, and even normal meditation, can be positive for overall health, experts caution that it should not be used as a singular treatment for certain conditions. TM training is available through a nonprofit organization called Maharishi Foundation. Training involves multi-session group courses with a certified instructor. Fox News Digital reached out to the Maharishi Foundation for comment.
Forbes
2 minutes ago
- Forbes
Pharma Companies Pour Billions Into US Manufacturing To Avoid Tariffs
NEW YORK, NEW YORK - MARCH 12: CEO of Eli Lilly and Company David Ricks speaks at the Economic Club ... More of New York on March 12, 2024 in New York City. The U.S. drugmaker Eli Lilly, has made strategic investments in US manufacturing. Pharmaceutical imports are on the chopping block, as President Trump is proposing a 200% tariff to boost domestic production and make pharmaceutical production in the US more competitive. The U.S. imported $212 billion in pharmaceuticals in 2024, making it the 5th most imported product. The deadline for this is August 1. Jena Santoro, Global Head of Research & Analytics at Everstream Analytics, states that the previously reported grace period of approximately one to one and a half years for pharmaceutical companies to relocate their manufacturing operations to the U.S. - before the tariffs take effect - appears to remain in place. This grace period would allow drug manufacturers time to adjust production strategies and investments. Everstream is a provider of AI-based supply chain risk management solutions. Tariffs are being wielded by this administration as leverage to force reciprocity, extract critical concessions, or safeguard national interests. The pharma industry is one in which this leverage appears to have had considerable success. Pharma Make Significant Investments in the US In response to the threat of tariffs, AstraZeneca, British Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK, reported on July 22 that it would invest $50 billion in U.S. production. A significant portion of this investment will be allocated to a new manufacturing center in Virginia. Upon completion, this facility will be the company's largest single manufacturing hub. CEO Pascal Soriot said the investment 'underpins our belief in America's innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally.' The company stated that the Virginia plant will anchor its U.S. expansion and serve as a key hub for future pharmaceutical manufacturing. The site will produce small molecules, peptides, and oligonucleotides using AI, automation, and data analytics to optimize production. AstraZeneca's $50 billion plan also includes expansions in Maryland, Massachusetts, Indiana, Texas, and California. The company's goal is to reach $80 billion in revenue by 2030, with half of that expected to come from the U.S. market. Roche, headquartered in Basel, Switzerland, also announced today that it will invest $50 billion into the US. The investment will be made over a five-year period. The company's commitment includes new research and development (R&D) sites, and new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts, and California. Roch says their investments will create more than 12,000 new jobs: 1,000 at Roche and more than 11,000 in support of new US manufacturing capabilities. Their manufacturing investments will include a gene therapy manufacturing facility in Pennsylvania, a new 900,000-square-foot manufacturing facility to support Roche's expanding portfolio of weight loss medicines (the location of this facility has not yet been announced), and a new manufacturing facility for continuous glucose monitoring in Indiana. Once all new and expanded manufacturing capacity comes online, Roche will export more medicines from the US than it imports. Even before the pharma tariff announcement, Eli Lilly (NYSE: LLY) had announced plans to invest $27 billion to build four new production facilities in the US. The goal of this is to strengthen the country's pharmaceutical supply chain. David Ricks, CEO of Eli Lilly, described the planned facilities as "mega sites." Three of Lilly's newly announced sites will be dedicated to producing active pharmaceutical ingredients, which are critical components in drug production. The fourth site will focus exclusively on injectable drugs. China dominates the production of active pharmaceutical ingredients. China's dominant role in producing APIs is widely viewed as a strategic threat, primarily due to the potential for disruptions to the global pharmaceutical supply chain if China chooses to halt these exports as a way of gaining geopolitical leverage. As relations with China fray, these investments will bring significant manufacturing capabilities back to American soil. "The real gap in the supply chain in the US relates to active ingredient availability," David said. "Importantly, two of those [facilities] will be for synthetic chemistries and these, in particular, have been absent from the landscape in the US for some time." BioGen (Nasdaq: BIIB), an American biotechnology company also based in Cambridge, UK, announced on July 21 a much smaller investment. The company will invest $2 billion in its existing manufacturing plants in North Carolina. However, the facility in North Carolina's Research Triangle Park (RTP) was already home to the company's largest manufacturing plants. These facilities produce key therapies for multiple sclerosis and Alzheimer's. However, Biogen remains committed to global manufacturing. 'Biogen's overall global manufacturing supply chain strategy aims at ensuring resilient and high-quality patient supply through robust risk management including geographical risk diversification and dual sourcing.' Pharmaceutical companies' more recent investments in the US have been driven by both incentives and tariff pressures. Merck (NYSE: MRK) started investing more heavily in the US following the 2017 Tax Cuts and Jobs Act. Since then, Merck has invested more than $12 billion into strengthening its US-based manufacturing and R&D infrastructure. The company plans to invest an additional $9 billion in domestic operations by 2028. Will the Tariffs Go Into Effect? Some of these planned investments are likely to be delayed or not implemented if the tariffs don't occur. The International Emergency Economic Powers Act grants the U.S. President broad authority to regulate economic transactions during a declared national emergency stemming from foreign threats. Traditionally, IEEPA has been used to impose sanctions and freeze assets, but the Trump administration has leveraged it to impose tariffs. This has created legal challenges. The next appellate hearing on the Trump administration's use of IEPPA is on July 31st. However, if the administration loses, TD Cowen expects them to expand its use of Section 232. This national security statute is designed to shield vital industries. These 'sector' tariffs have been announced for steel, aluminum & global autos/parts. Open investigations are focused on copper, lumber, semi-trucks and parts, critical minerals, aircraft & jet engines, and pharmaceuticals. TD Cowen is a US multinational investment bank and financial services division of TD Securities.
New York Post
an hour ago
- New York Post
Higher cancer rates linked to WWII waste in Midwestern creek
A Missouri creek has allegedly led to a higher risk of cancer in neighboring residents. Coldwater Creek, a Missouri River tributary north of St. Louis, has been a known radioactive waste site since the 1980s. Researchers have now confirmed that exposure to the creek, which is said to be polluted with nuclear waste from the development of the first atomic bomb, has led to an increased incidence of cancer for people who were children in the area between the 1940s and 1960s. A study from the Harvard T.H. Chan School of Public Health, which was published in JAMA Network, analyzed the data of 4,209 participants who lived near Coldwater Creek. The data was originally gathered for a previous study on childhood radiation exposure. Participants who lived in the Greater St. Louis area between 1958 and 1972 shared their cancer diagnoses, which allowed researchers to calculate risk based on their proximity to the creek. 4 Researchers have now confirmed that exposure to the Coldwater Creek has led to an increased incidence of cancer for children in the area between the 1940s and 1960s, due to nuclear waste. AP The researchers found an elevated risk of cancer in a long-term follow-up, with those who lived closest to the creek reporting a higher incidence of most cancers. 'The waste from these entities could have huge impacts on people's health, even at lower levels of exposure.' In total, 24% of study participants reported having cancer. Of those, 30% lived less than one kilometer away from the creek, 28% lived between one and five kilometers away, 25% lived between five and 20 kilometers away, and 24% lived more than 20 kilometers away. 4 Susie Gaffney poses for a photo along Coldwater Creek near where she used to live Friday, April 7, 2023. AP 4 24% of study participants reported having cancer, and 30% of that percentage lived less than one kilometer away from the creek. REUTERS Corresponding author Marc Weisskopf, professor of environmental epidemiology and physiology at Harvard T.H. Chan School of Public Health, commented on these findings in a press release. 'Our research indicates that the communities around North St. Louis appear to have had excess cancer from exposure to the contaminated Coldwater Creek,' he said. 'These findings may have broader implications — as countries think about increasing nuclear power and developing more nuclear weapons, the waste from these entities could have huge impacts on people's health, even at these lower levels of exposure.' This study accompanies Congress' passing of an expanded version of the Radiation Exposure Compensation Act (RECA), as part of President Trump's Big Beautiful Bill. The act will allow Americans, including Coldwater Creek residents, to receive compensation for medical bills associated with radiation exposure, the researchers noted. 4 This study accompanies Congress' passing of an expanded version of the Radiation Exposure Compensation Act, which would allow Americans to receive compensation for medical bills associated with radiation exposure. AP Local agencies have become increasingly concerned about cancer prevalence in the area, prompting the push for further research beyond the U.S. government's acknowledgment of the pollution four decades ago. The contamination originally occurred due to the Manhattan Project and Mallinckrodt Chemical Works, which processed and refined uranium in St. Louis, according to the study. The radioactive material was moved out of the major U.S. city and into the more rural area near Coldwater Creek, where it was stored in uncovered drums on the ground and exposed to the elements, allowing contaminants to leach into the nearby creek. The researchers noted that communities downstream from Coldwater Creek had potentially been exposed to the ionizing radiation during recreational activities, such as playing in the creek, and residential activities, like breathing in dust suspended from the soil when gardening. The study did have some limitations, the researchers acknowledged, including its small sample size and reliance on self-reported cancer outcomes. The potential carcinogenic impact of creek exposure warrants further research to confirm the findings, the team concluded. Co-author Michael Leung, PhD, post-doctoral research fellow at Harvard's Department of Environmental Health, reflected on the findings in an interview with Fox News Digital. 'Our study found that children in the 1940s to 1960s who lived near Coldwater Creek, which was contaminated by radioactive waste from the development of the first atomic bomb, had a 44% higher risk of cancer compared to those living further than 20 kilometers away,' he confirmed. 'Our findings coincide with Congress passing an expanded version of the Radiation Exposure Compensation Act, and gives further credence to the health concerns of St. Louis area-residents about the contaminated creek,' Leung went on. 'We hope these findings will support public health measures for affected communities, as well as ongoing efforts to remediate the creek.'
